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were analyzed by polymerase chain reaction techniques for de-
tection of the fragments of ORF K1 of HHV-8, which were then
genotyped and analyzed regarding the genetic variability. Our
study described 106 positive cases for HHV-8 in the saliva from
751 AIDS patients without previous KS. In addition, we per-
formed a phylogenetic analysis of HHV-8 in 34 of the 106 AIDS
patients without KS and in 33 of the 37 patients with active KS.
The distribution of HHV-8 genotypes A, B, C, and F in AIDS indi-
viduals was indistinguishable by comparing non-KS and KS
groups, as well as regarding ethnicity. Considering the KS group,
genotype B was associated with better prognosis of KS tumor.
Interestingly, we found a particular profile of diversity within
clade C and two recombinant patterns of HHV-8 in the saliva of
AIDS individuals without KS. We emphasize the need to achieve
standard genotyping protocol for ORF K1 amplification, thus al-
lowing for substantial detection of HHV-8 variants. Our findings
can shed light on the role of HHV-8 variability in the pathogene-
sis of AIDS-KS. Our perspective is study polymorphisms and
phylogenetic inferences in HHV-8 sequences encoding
microRNA.
A51 Rubella genotype 1H is still circulating in Turkey
Tulay Yalcinkaya
Virology Laboratory, Public Health Institution of Turkey, Sihhiye-
06100, Ankara
Rubella virus, the sole member of the Rubivirus genus in the
Togaviridae family, is a positive-strand RNA virus. Based on phy-
logenetic analysis of sequences of the structural coding protein,
two virus clades including a total of thirteen genotypes have been
identified. Infection with rubella virus generally leads to mild dis-
ease with symptoms that include rash and low fever. In preg-
nancy, however, rubella infection can cause miscarriages and
serial birth defects including hearing, vision, mental and heart
impairment, which are collectively known as congenital rubella
syndrome (CRS). CRS occurs in up to 85 per cent of children born
to women with rubella infection during the first trimester of preg-
nancy. In addition, CRS can lead to neonatal deaths in up to 30
per cent of cases. Laboratory investigation plays an important
role in both diagnosis and surveillance of rubella and CRS, since
clinical diagnosis is unreliable and up to 50 per cent of infections
are estimated to be subclinical. Because phylogenetic analysis of
rubella virus genotypes can help determine whether circulating
strains result from endemic transmissions or importations, labo-
ratory surveillance for rubella also includes the molecular charac-
terisation of viruses. Rubella genotype 1 H was detected in a
seven-year-old patient’s urine specimen in 2016 (GenBank acces-
sion number KY048160). There are only three previous genotype
1 H sequences from Turkey which were collected in 2001. No se-
quences are available from countries bordering Turkey (except
for one 2B from Iran). Other 1 H sequences are mostly from
Russia and Belarus and none have been detected since 2008. The
sequences of the recent isolate and three previous isolates cluster
as a separate branch of genotype 1 H. It seems likely that this lin-
eage of 1 H has been circulating in the country (and perhaps bor-
dering countries) during the last fifteen years.
A52 Ebola virus phylogenetic analysis during the 2014–2016West
African outbreak
Shannon L. M. Whitmer and Ute Stro¨her
Viral Special Pathogens Branch, Centers for Disease Control and
Prevention, Atlanta, GA, USA
Following the conclusion of active Ebolavirus disease (EVD) trans-
mission within West Africa, sporadic EVD-cases continued to
re-emerge outside of the expected viral incubation period.
Epidemiological evidence suggested that these cases represented
sexual transmission from persistently infected, asymptomatic
EVD survivors. To address these questions, we directly se-
quenced EBOV from clinical specimens collected during acute
and persistent infection from individuals associated with these
re-emerged EVD cases. This sequence analysis was used in con-
junction with on-the-ground epidemiological tracing to identify
transmission chains and potential routes of infection. Due to a
lack of knowledge regarding the effect of persistence on Ebola vi-
ral sequences, we were unable to support or refute whether these
re-emerged cases represented evidence of transmission from
EVD survivors, despite extensive phylogenetic analysis. To ad-
dress this knowledge gap, we also sequenced Ebola virus directly
from the semen of EVD survivors (‘SAVS’—semen-acquired viral
sequences) and identified molecular characteristics associated
with viral persistence. Through extensive use of phylogenetic
software and models, we identified that a subset of SAVS ex-
hibited evidence of a slowed or acute-like substitution rates, de
novo U-to-T hyper-editing and a moderate change in evolution-
ary pressure within the viral glycoprotein. Altogether, our data il-
lustrate that phylogenetic analysis and evolutionary hypothesis
testing can yield important insights into disease transmission
networks and the mechanisms of viral replication.
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Unbiased metagenomics sequencing allows the detection of
any potential pathogen in a sample using a single methodology.
This technique has been used to successfully identify patho-
gens in case reports of patients with central nervous system
(CNS) infection. Metagenomics sequencing also provides geno-
mic information that can be used to classify pathogens and per-
form studies of molecular epidemiology, especially for viruses,
which have small genomes amenable to full-genome sequenc-
ing. Here, we apply metagenomics sequencing to detect and se-
quence viruses in a prospective cohort of patients with CNS
infection. We enroll patients with both known (control) and un-
known or suspected CNS infection and obtain samples of cere-
brospinal fluid. We perform unbiased library construction from
both RNA and DNA, followed by deep sequencing and metage-
nomics analysis. In patients with known infections, we have
successfully sequenced Herpes Simplex Virus (HSV)-1 in two
cases and HSV-2 in one case, obtaining partial genomes that al-
lowed species classification. We have also successfully se-
quenced enterovirus in two cases, obtaining full-length viral
genomes that allowed strain classification and phylogenetic
analysis. In one patient with unknown infection, we identified
Powassan virus, an emerging tick-borne flavivirus that causes
encephalitis in the Northeastern United States. In that case, our
NGS results were obtained three weeks earlier than routine clin-
ical testing by serology, highlighting the potential application of
this method for rapid diagnosis of infection. As work in prog-
ress, we are currently sequencing the full viral genome, which
will be the first Powassan virus genome sequenced directly
from a clinical sample. This will allow phylogenetic comparison
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to genomes isolated from tick vectors in order to assess whether
there are viral characteristics associated with human infection.
Overall, our results highlight the utility of metagenomics NGS to
identify and study the molecular epidemiology of viruses that
cause CNS infection.
A54 Viral metagenomics: Relative viral enrichment and detection
limits in clinical serum and faeces
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Any etiological agent containing nucleic acids should be identi-
fiable using random next-generation sequencing (NGS) of hu-
man clinical materials. Unlike PCR based and baiting strategies,
random NGS metagenomics is able to identify unknown and ge-
netically drifted agents without relying on prior knowledge.
This makes it suitable for the identification of RNA-viruses,
which naturally drift due to their error-prone RNA-dependent
RNA polymerase. However, NGS applied to virome investigation
(viral metagenomics) presents biological and technical barriers.
Viruses often cannot be cultured or isolated, therefore, low viral
load samples are common. Furthermore, during NGS, all nucleic
acid molecules compete for limited sequencing capacity
(whether viral or non-viral) and the costs of NGS increases pro-
portional with required sequencing depth. Therefore, to effi-
ciently sequence low viral load samples, a protocol has to be
developed that enriches viruses/viral nucleic acid. We first fo-
cused on single stranded RNA-viruses in serum and faeces.
Different stages of the protocol were tested in the process from
RNA-virus positive sample to dsDNA input for NGS: centrifuga-
tion, filtration, endonuclease treatment, RNA extraction, re-
verse transcription, second strand synthesis and library
preparation. Different combinations of these methods were ap-
plied to human faeces and serum and assessed using qPCR.
Subsequently, the optimal method was applied to Chikungunya
virus positive serum and norovirus positive faeces ranging from
Ct eight and eleven up to Ct 35 and 30, respectively. Lastly, these
samples were sequenced using an Illumina MiSeq (PE300, 106
reads/sample) and analyzed to determine detection limits. Our
method reliably generates full (>95 per cent) viral genomes up
to Ct 26 in both serum and faeces, while allowing identification
of viral agent up to Ct 30. Viral metagenomics proved its merit
by also identifying sapovirus, coxsackievirus, parechovirus, and
picobirnavirus in faeces. The coxsackievirus and parechovirus
were confirmed using qPCR with a Ct of 28 and 29.18, respec-
tively. The identified sapovirus could not be confirmed using
our diagnostic qPCR, although NGS data coverage indicated a
high viral load. Further analysis of this sapovirus showed many
mutations in the qPCR primer binding site, explaining the nega-
tive result in our diagnostic assay. These results emphasize the
power and promise of viral metagenomics.
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The rapid evolution of pathogenic RNA viruses presents a major
challenge for scientists and others fighting to control transmis-
sion, predict and prevent future epidemics. Foot-and-mouth
disease virus (FMDV), the picornavirus responsible for the epon-
ymous disease, is one of the costliest livestock pathogens across
much of the globe. Understanding how the virus changes over
time both within hosts and through chains of transmission is of
central importance for vaccine development, vaccination and
quarantine strategies and international trade regulations.
Cloven-hoofed animals including swine, cattle, and other do-
mesticated and wild bovids are susceptible to the disease.
Importantly, cattle and buffalo can be long-term carriers of the
virus with the role of these animals in transmission being an ac-
tive subject of research. Recent publications examining the full-
length FMDV genome have begun to explain the complexities of
the quasispecies and its behavior through transmission events
and within hosts. Several of our lab’s recent publications have
addressed the question of which factors are responsible for in-
ducing the carrier state. Our current endeavors build upon these
concepts with detailed genomic study of FMDV in experimen-
tally infected cattle through the acute and persistent phases of
infection. Beginning with a heterogeneous inoculum mirroring
the diversity that might be seen in an intensive farm outbreak,
we have followed the progression of consensus genomes in
twelve steers through different stages of disease including incu-
bation, clinical disease, and the post-acute carrier state. In this
study, we have documented convergent novel mutations at the
canonical host cell entry RGD motif. We also characterized di-
vergent minority genomes that, through powerful selective
sweeps, became dominant at distinct points of infection. This
study included both vaccinated and unvaccinated animals, with
protection correlating with different patterns of viral evolution,
notably at major antigenic sites. This is the first study to evalu-
ate the full consensus genome of FMDV at distinct stages of in-
fection, thus revealing significant micro-evolutionary events
that can be of substantial benefit to disease control strategies
and epidemiological modeling. The next stage of this work, sup-
ported by preliminary NGS data, will incorporate quasispecies-
level analysis, elucidating the dynamic selective and population
pressures during viral infection.
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Foot-and-mouth disease (FMD) is one of the most important
diseases of livestock worldwide. The causative agent, FMD virus
(FMDV) is an aphthovirus from the Picornaviridae. The FMDV
ORF is translated as a single polyprotein that codes for four
structural proteins and eight non-structural proteins. Molecular
epidemiology and evolution of FMDV have been traditionally
studied using the sequence coding for VP1 (639 nt), the capsid
protein containing most relevant antigenic domains. Although
full-genome sequencing of this virus is not used as a routine di-
agnostic or surveillance tool, the availability of full-genome se-
quences in public repositories has increased over recent years.
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